EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSCHOG00000003611
Gene Symbol: DHCR24
1 Cross references
209 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSCHOG00000012101
Gene Symbol: HMGCR
1 Cross references
272 Possible Orthologues:

5-Hydroxytryptamine Receptor 1f

Ensembl ID : ENSCHOG00000012080
Gene Symbol: HTR1F
1 Cross references
146 Possible Orthologues:

5-Hydroxytryptamine Receptor 2a

Ensembl ID : ENSCHOG00000011020
Gene Symbol: HTR2A
1 Cross references
217 Possible Orthologues:

5-Hydroxytryptamine Receptor 2b

Ensembl ID : ENSCHOG00000002323
Gene Symbol: HTR2B
1 Cross references
207 Possible Orthologues:

5-Hydroxytryptamine Receptor 3b

Ensembl ID : ENSCHOG00000003440
Gene Symbol: HTR3B
1 Cross references
175 Possible Orthologues:

5-Hydroxytryptamine Receptor 3e

Ensembl ID : ENSCHOG00000011755
Gene Symbol: HTR3E
1 Cross references
38 Possible Orthologues:

5-Hydroxytryptamine Receptor 4

Ensembl ID : ENSCHOG00000011179
Gene Symbol: HTR4
1 Cross references
201 Possible Orthologues:

5-Hydroxytryptamine Receptor 5a

Ensembl ID : ENSCHOG00000009734
Gene Symbol: HTR5A
1 Cross references
216 Possible Orthologues:

Adam Metallopeptidase Domain 17

Ensembl ID : ENSCHOG00000000187
Gene Symbol: ADAM17
1 Cross references
283 Possible Orthologues:

Adam Metallopeptidase With Thrombospondin Type 1 Motif 5

Ensembl ID : ENSCHOG00000002348
Gene Symbol: ADAMTS5
1 Cross references
199 Possible Orthologues:

Akt Serine/threonine Kinase 3

Ensembl ID : ENSCHOG00000008755
Gene Symbol: AKT3
1 Cross references
201 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).